Relypsa

Relypsa Gets More Attractive For Merck, Sanofi
Bidness, ETC
Wed, 12/23/15 - 09:26 pm
Relypsa
Merck
Sanofi
M&A
8 BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sat, 10/24/15 - 02:28 pm
AbbVie
Gilead Sciences
Endo International
Synta Pharmaceuticals
Valeant Pharmaceuticals
Relypsa
Repros Therapeutics
Ocular Therapeutix
Relypsa's Veltassa Will Be Embraced By Physicians
Seeking Alpha
Thu, 10/22/15 - 07:25 pm
Relypsa
Veltassa
physicians
hyperkalemia
Relypsa, Sanofi marketing teams revved up and waiting for FDA nod on patiromer
Fierce Pharma Marketing
Wed, 10/21/15 - 09:13 pm
Sanofi
Relypsa
patiromer
hyperkalemia
Sanofi adds its sales heft to Relypsa's forthcoming patiromer launch
Fierce Pharma Marketing
Sat, 08/15/15 - 10:52 am
Sanofi
Relypsa
drug launches
drug reps
hyperkalemia
patiromer
Encouraging Results For Two New Drugs That Fight A Common And Dangerous Side Effect
Forbes
Fri, 11/21/14 - 03:10 pm
RAAS
ZS Pharma
hyperkalemia
ZS-9
Relypsa
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Wed, 07/2/14 - 11:49 am
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin
Biotech IPOs Are Back To Normal
Seeking Alpha
Tue, 11/26/13 - 08:51 am
biotech
IPOs
Agios Pharmaceuticals
Omthera
Relypsa
Trio of IPO setbacks strike sour note at biotech's Wall Street party
Fierce Biotech
Thu, 11/14/13 - 11:06 am
biotech
IPOs
Relypsa
Xencor
Celladon

Pages